Research Article

Comparison of a Novel Herbal Medicine and Omeprazole in the Treatment of Functional Dyspepsia: A Randomized Double-Blinded Clinical Trial

Table 2

The mean score of GSRS scale and subscales of GSRS Dyspepsia and GSRS Pain. Intention-to-treat population.

ScaleGroupMean baseline (±s.d.)Mean week 2 (±s.d.)Mean CBTW2 (±s.d.)Mean week 4 (±s.d.)Mean C2WAT (±s.d.)

GSRSControl ()42.3 (7)0.1722 (9.9)20.3) 7)29 (13.5)7.7 (6.3)
Intervention ()44.5 (7.4)9.4 (4.2)35.1 (9.9)13.6 (5.7)4.1 (4.3)

GSRS DyspepsiaControl ()17.9 (3.2)0.887.2 (4)10.6 (4.6)10.1 (5.8)3.4 (3.6)
Intervention ()18.4 (2.1)3.5) 2.4)14.8) 3.1)4.7 (3.1)1.2 (1.9)

GSRS PainControl ()12.2) 2.7)0.865.1 (3.5)7 (3.9)7 (5.5)3.1 (3.2)
Intervention ()12.1 (2.2)2.4 (1.9)9.7 (2.7)2.9 (2.4)1.5 (2)

: value; GSRS: Gastrointestinal Symptom Rating Scale; Mean CBTW2: mean change baseline to week 2; Mean C2WAT: mean change 2 week after treatment; control vs. intervention; control vs. intervention; control vs. intervention; week 2 vs. baseline. Control (omeprazole), intervention (Herbal medicine).